Adrenoceptor agonists and antagonists and risk of Parkinson's disease

Mov Disord. 2019 Mar;34(3):442. doi: 10.1002/mds.27611.

Authors

Helia Maghzi¹, Elliot J Hogg¹, Echo Tan¹, Gennaro Pagano², Michele Tagliati¹

Affiliations

¹ Department of Neurology, Cedars Sinai Medical Center, Los Angeles, California, USA.
² Neurodegeneration Imaging Group, King's College London, London, United Kingdom.

PMID: 30875150
DOI: 10.1002/mds.27611

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Parkinson Disease*
Receptors, Adrenergic

Substances

Receptors, Adrenergic